Cleveland Clinic Akron General
Akron, Ohio, 44307, United States
NCT Number: NCT05252832
This is a prospective randomized trial evaluating the effect of SCPB on reported patient pain following IJCL placement as compared to local infiltrate.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Akron, Ohio, 44307, United States
The goal of this study is to determine if SCPBs provide more pain control than local infiltrate of anesthetic for internal jugular venous cannulation. The investigators hypothesis that patients who receive the SCPB will have a lower VAS rating on average than those who receive local infiltration following internal jugular venous cannulation. To test this, the investigators will be approaching eligible patients for inclusion in a research study. If the patients consent, the patients will be randomly assigned the standard of care treatment or the SCPB. The investigators will then ask the patients to rate pain following insertion of the central line. The investigators will also evaluate different aspects of the patient's hospital course to evaluate their outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Location of injection for block.
Local infiltration location.
Time frame: 30 minutes post central line placement
The average Visual Analog Scale (VAS) rating in patients who receive the SCPB during internal jugular venous cannulation versus the average VAS in patients receiving local infiltration. The scale is from 0-10, with 0 meaning no pain and 10 meaning the most pain I have ever experienced.
Time frame: Duration of emergency department and inpatient encounter, typically no more than 7 days.
To determine if SCPBs are associated with higher complication rates than local infiltration with internal jugular venous cannulation. Complications will be defined as arterial injury, lacerations of the vena cava, mediastinal vessels, and right atrium, hematoma formation, retained guide wire, pulmonary complications including pneumothorax, pneumomediastinum, chylothorax, tracheal injury, injury to the recurrent laryngeal nerve, and air embolus, tracheal injury, arrhythmia, cardiac arrest, device dysfunction, device infection, and venous thrombosis.
Cleveland Clinic Akron General
Other
Evaluation of the Efficacy of the Superficial Cervical Plexus Block in Reducing Pain Associated With Internal Jugular Central Lines
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06660875
Acute Pain, Neurologic Manifestations
Yenimahalle, Ankara, Turkey (Türkiye)
View Trial DetailsNCT07057739
Adjuvants, Bupivacaine
Kafr ash Shaykh, Kafr Elsheikh, Egypt
View Trial DetailsNCT06146179
Anterior Suprascapular Nerve Block, Arthralgia
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07338916
Brachial Plexus Blockade, Shoulder Surgery
Providencia, Chile
View Trial Details